Anaphylactoid reaction to atracurium.
Atracurium is a new intermediate-acting muscle relaxant, relatively devoid of cardiovascular effect in the clinical dose range. Histamine release is reported in a dose-dependent fashion, but below the threshold for haemodynamic effect within the recommended dose limits. We report a case of an anaphylactoid reaction to a low dose (0.2 mg X kg-1) of atracurium, and discuss the peculiar aspects of this case that predisposed the patient to this event.
D000368:Aged; D000707:Anaphylaxis / Q000139:chemically induced* / Q000188:drug therapy; D000767:Anesthesia, Epidural; D001279:Atracurium / Q000009:adverse effects*; D004837:Epinephrine / Q000627:therapeutic use; D006801:Humans; D008297:Male
D001279:Atracurium; D004837:Epinephrine